A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma

Clinical trial NCT00668148 · COMPLETED

Trial details

NCT number: NCT00668148
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET)Rhabdomyosarcoma Leiomyosarcoma Adipocytic Sarcoma Synovial Sarcoma

Start date: 2008-07-01
Primary completion: 2010-10-01
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.